Brian D Tait

Summary

Affiliation: Australian Red Cross Blood Service
Country: Australia

Publications

  1. ncbi HLA class I expression on human cancer cells. Implications for effective immunotherapy
    B D Tait
    Victorian Transplantation and Immunogenetics Service Australian Red Cross Blood Services, Parkville, Victoria, Australia
    Hum Immunol 61:158-65. 2000
  2. ncbi Solid phase HLA antibody detection technology--challenges in interpretation
    B D Tait
    National Transplant Services, Australian Red Cross Blood Service, Melbourne, Australia
    Tissue Antigens 76:87-95. 2010
  3. ncbi In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype
    Hector Chinoy
    Rheumatic Diseases Centre, Hope Hospital, Salford, UK
    Arthritis Res Ther 8:R13. 2006
  4. ncbi Review article: Luminex technology for HLA antibody detection in organ transplantation
    Brian D Tait
    Victorian Transplantation and Immunogenetic Service, Australian Red Cross Blood Service, Parkville, Victoria, Australia
    Nephrology (Carlton) 14:247-54. 2009
  5. ncbi 14th International HLA and Immunogenetics Workshop: report on HLA expression and cancer
    B D Tait
    Victorian Transplantation and Immunogenetic Service, Melbourne, Australia
    Tissue Antigens 69:245-7. 2007
  6. ncbi Allocation of cadaver donor kidneys in Australia
    Brian D Tait
    Victorian Transplantation and Immunogenetics Service, Australian Red Cross Blood Service, Royal Melbourne Hospital, Parkville Victoria, Australia
    Transplantation 77:627-9. 2004
  7. ncbi Solid phase assays for HLA antibody detection in clinical transplantation
    Brian D Tait
    Victorian Transplantation and Immunogenetic Service, Australian Red Cross Blood Service, 2nd Floor Rotary Bone Marrow Research Building, c o Royal Melbourne Hospital, Grattan St, Parkville 3050, Australia
    Curr Opin Immunol 21:573-7. 2009
  8. ncbi The ever-expanding list of HLA alleles: changing HLA nomenclature and its relevance to clinical transplantation
    Brian D Tait
    National Transplant Services, Australian Red Cross Blood Service, Melbourne, Australia
    Transplant Rev (Orlando) 25:1-8. 2011
  9. ncbi Human leukocyte antigen mismatch and other factors affecting cryopreserved allograft valve function
    Cheng Hon Yap
    Department of Cardiothoracic Surgery, St Vincent s Hospital, Melbourne, Australia
    Heart Surg Forum 11:E42-5. 2008
  10. ncbi Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity
    Diana Chessman
    Department of Microbiology and Immunology, The University of Melbourne, Parkville, Victoria 3010, Australia
    Immunity 28:822-32. 2008

Collaborators

Detail Information

Publications27

  1. ncbi HLA class I expression on human cancer cells. Implications for effective immunotherapy
    B D Tait
    Victorian Transplantation and Immunogenetics Service Australian Red Cross Blood Services, Parkville, Victoria, Australia
    Hum Immunol 61:158-65. 2000
    ..The identification of appropriate monoclonal antibody reagents for class I expression and techniques used on different kinds of tissue sections will be a component of the forthcoming 13th International Histocompatibility Workshop...
  2. ncbi Solid phase HLA antibody detection technology--challenges in interpretation
    B D Tait
    National Transplant Services, Australian Red Cross Blood Service, Melbourne, Australia
    Tissue Antigens 76:87-95. 2010
    ..The advantages of bead technology for HLA antibody determination and the technical issues requiring resolution are the subject of this review...
  3. ncbi In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype
    Hector Chinoy
    Rheumatic Diseases Centre, Hope Hospital, Salford, UK
    Arthritis Res Ther 8:R13. 2006
    ..In conclusion, these findings support the notion that myositis patients with differing myositis serology have different immunogenetic profiles, and that these profiles may define specific myositis subtypes...
  4. ncbi Review article: Luminex technology for HLA antibody detection in organ transplantation
    Brian D Tait
    Victorian Transplantation and Immunogenetic Service, Australian Red Cross Blood Service, Parkville, Victoria, Australia
    Nephrology (Carlton) 14:247-54. 2009
    ..Luminex technology will permit a re-evaluation of the role of HLA antibodies in both early and late antibody-mediated rejection...
  5. ncbi 14th International HLA and Immunogenetics Workshop: report on HLA expression and cancer
    B D Tait
    Victorian Transplantation and Immunogenetic Service, Melbourne, Australia
    Tissue Antigens 69:245-7. 2007
  6. ncbi Allocation of cadaver donor kidneys in Australia
    Brian D Tait
    Victorian Transplantation and Immunogenetics Service, Australian Red Cross Blood Service, Royal Melbourne Hospital, Parkville Victoria, Australia
    Transplantation 77:627-9. 2004
    ..Kidneys that do not reach the level of matching required for national allocation are transplanted in the donor state using both matching and waiting time criteria, which caters to minority groups with rare HLA types...
  7. ncbi Solid phase assays for HLA antibody detection in clinical transplantation
    Brian D Tait
    Victorian Transplantation and Immunogenetic Service, Australian Red Cross Blood Service, 2nd Floor Rotary Bone Marrow Research Building, c o Royal Melbourne Hospital, Grattan St, Parkville 3050, Australia
    Curr Opin Immunol 21:573-7. 2009
    ..The role in allograft rejection of antibody titre and non-complement fixing antibodies, which are also detected by these methods, are areas currently under consideration...
  8. ncbi The ever-expanding list of HLA alleles: changing HLA nomenclature and its relevance to clinical transplantation
    Brian D Tait
    National Transplant Services, Australian Red Cross Blood Service, Melbourne, Australia
    Transplant Rev (Orlando) 25:1-8. 2011
    ....
  9. ncbi Human leukocyte antigen mismatch and other factors affecting cryopreserved allograft valve function
    Cheng Hon Yap
    Department of Cardiothoracic Surgery, St Vincent s Hospital, Melbourne, Australia
    Heart Surg Forum 11:E42-5. 2008
    ..Recipient age remained the strongest predictor of valve dysfunction. These results indicate that allograft ischemic times should be minimized...
  10. ncbi Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity
    Diana Chessman
    Department of Microbiology and Immunology, The University of Melbourne, Parkville, Victoria 3010, Australia
    Immunity 28:822-32. 2008
    ....
  11. ncbi Natural HLA class I polymorphism controls the pathway of antigen presentation and susceptibility to viral evasion
    Danielle Zernich
    Department of Microbiology and Immunology, The University of Melbourne, Parkville, Victoria 3010, Australia
    J Exp Med 200:13-24. 2004
    ..These findings unveil a new layer of MHC polymorphism that affects the generic pathway of Ag loading, revealing an unsuspected evolutionary trade-off in selection for optimal HLA class I loading versus effective pathogen evasion...
  12. ncbi A polymorphism in the HLA-DPB1 gene is associated with susceptibility to multiple sclerosis
    Judith Field
    Florey Neuroscience Institutes, University of Melbourne, Melbourne, Victoria, Australia
    PLoS ONE 5:e13454. 2010
    ..It is correlated with the HLA-DPB1*03:01 allele, which has been implicated previously in MS in smaller studies. Further genotyping in large datasets is required to confirm and resolve this association...
  13. ncbi Anti-HLA antibodies after cryopreserved allograft valve implantation does not predict valve dysfunction at three-year follow up
    Cheng Hon Yap
    Department of Cardiothoracic Surgery, St Vincent s Hospital, Melbourne, PO Box 2900, Fitzroy, VIC 3065, Australia
    J Heart Valve Dis 15:540-4. 2006
    ..As the cause of allograft heart valve degeneration is poorly understood, the study aim was to investigate the host antibody response to allograft valve implantation...
  14. ncbi HLA DPA1, DPB1 alleles and haplotypes contribute to the risk associated with type 1 diabetes: analysis of the type 1 diabetes genetics consortium families
    Michael D Varney
    Department of Surgery, Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York, USA
    Diabetes 59:2055-62. 2010
    ..To determine the relative risk associated with DPA1 and DPB1 alleles and haplotypes in type 1 diabetes...
  15. ncbi Identification of a novel DPB1* allele (DPB1*6901) and the occurrence of HLA haplotypes that extend to DPB1
    M D Varney
    Victorian Transplantation and Immunogenetics Service, Australian Red Cross Blood Services, Parkville
    Tissue Antigens 55:188-90. 2000
    ....
  16. ncbi The effect of folinic Acid on methylenetetrahydrofolate reductase polymorphisms in methotrexate-treated allogeneic hematopoietic stem cell transplants
    Nicholas M Murphy
    Department of Pharmaceutical Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia
    Biol Blood Marrow Transplant 18:722-30. 2012
    ..Use of FA following transplantation should be reconsidered in the context of patient and donor MTHFR genotypes...
  17. ncbi HLA genes associated with autoimmunity and progression to disease in type 1 diabetes
    B D Tait
    Victorian Transplantation and Immunogenetics Service, Australian Red Cross Blood Service, Melbourne, Victoria, Australia
    Tissue Antigens 61:146-53. 2003
    ....
  18. ncbi A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition
    Whitney A Macdonald
    Dept. of Microbiology and Immunology, The University of Melbourne, Parkville, Victoria 3010, Australia
    J Exp Med 198:679-91. 2003
    ..The findings suggest that these closely related class I genes are maintained in diverse human populations through their differential impact on the selection of peptide ligands and the T cell repertoire...
  19. ncbi Quantitative and functional diversity of cross-reactive EBV-specific CD8+ T cells in a longitudinal study cohort of lung transplant recipients
    Nicole A Mifsud
    Department of Medicine, Monash University, Central Clinical School, The Alfred Hospital, Melbourne, Victoria, Australia
    Transplantation 90:1439-49. 2010
    ....
  20. ncbi The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes
    Spiros Fourlanos
    Autoimmunity and Transplantation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia
    Diabetes Care 31:1546-9. 2008
    ..To examine these possibilities, human leukocyte antigen (HLA) class II DRB1 genes known to confer risk for type 1 diabetes were analyzed in relation to year of birth and age at diagnosis over the last five decades...
  21. ncbi Immunodominance hierarchies and gender bias in direct T(CD8)-cell alloreactivity
    N A Mifsud
    Department of Microbiology and Immunology, The University of Melbourne, Royal Parade, Parkville, Victoria, Australia
    Am J Transplant 8:121-32. 2008
    ....
  22. ncbi SNP mapping and candidate gene sequencing in the class I region of the HLA complex: searching for multiple sclerosis susceptibility genes in Tasmanians
    R K Burfoot
    Howard Florey Institute, University of Melbourne, Melbourne, Victoria, Australia
    Tissue Antigens 71:42-50. 2008
    ..We have therefore identified plausible candidates for the causal MS susceptibility allele, and although not conclusive at this stage, our data provide suggestive evidence for multiple class I MS susceptibility genes...
  23. ncbi HLA expression and cancer--14th IHIWS immunohistochemistry quality control exercise exchange results
    S F Chew
    Victorian Transplantation and Immunogenetic Service, Melbourne, Australia
    Tissue Antigens 69:248-51. 2007
    ..It is suggested that further exercises are conducted as part of future collaborative activities in order to further characterise areas of variability between IH performance and interpretation of results...
  24. ncbi Markers on distal chromosome 2q linked to insulin-dependent diabetes mellitus
    G Morahan
    Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Victoria, Australia
    Science 272:1811-3. 1996
    ..These results indicate the existence of a gene that acts at an early stage in IDDM development, screening for which may identify a specific subset of at-risk individuals...
  25. ncbi Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele
    G Morahan
    The Walter and Eliza Hall Institute of Medical Research, PO Royal Melbourne Hospital, Victoria, Australia
    Nat Genet 27:218-21. 2001
    ..The IL12B 3' UTR alleles showed different levels of expression in cell lines. Variation in IL-12p40 production may influence T-cell responses crucial for either mediating or protecting against this and other autoimmune diseases...
  26. ncbi Nucleotide sequences of the HLA-DRw12 and DRw8 B1 chains from an Australian aborigine
    R M O'Brien
    Burnet Clinical Research Unit, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia
    Hum Immunol 34:147-51. 1992
    ..DRB RFLP studies on this cell line using the Taq I restriction enzyme indicated bands previously described for the DRw8 and DRw12 haplotypes...
  27. ncbi Interferon-gamma and interleukin-4 gene polymorphisms in Caucasian idiopathic inflammatory myopathy patients in UK
    Hector Chinoy
    The University of Manchester Rheumatic Diseases Centre, Salford M6 8HD, UK
    Ann Rheum Dis 66:970-3. 2007
    ..To determine whether interferon-gamma (IFN-gamma) and interleukin-4 (IL-4) genes confer susceptibility for the idiopathic inflammatory myopathies (IIMs)...